ABSTRACT
This study evaluated the efficacy of mirazid [Commiphora molmol] in the treatment of parasitologically and clinically and ultrasonography confirmed cases of Schistosomiasis haematobium in Tatoon Village. A total of 70 out of 885 individuals of both sexes [>15-60 years old] screened for S. haematobium infection was selected. They had a light infection [1-10 eggs/10 ml], moderate infection [10-100 eggs/10 ml] and heavy infection [>100/10 ml]. They were subjected to urine and stool analysis, renal function tests, clinical examination and abdomino-pelvic ultrasound. They were treated with mirazid as 10 mg/kg. However, eight of them were unable to swallow the drug. Out of the 62 Schistosomiasis haematobium patients, 57 were cured after two-month follow up and the cure rate reached 95.2% on the 3rd month post-mirazid treatment. The cure result was evaluated clinically, parasitologically and ultrasonographically